The prospectus is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any other jurisdiction in which such release, publication or distribution would be unlawful.
Neither the delivery of the prospectus nor the issue, sale or
delivery of any note shall, in any circumstances, create any
implication that the information contained in the prospectus is true
subsequent to the date thereof or, if the prospectus is supplemented
after the date thereof, the date of the relevant supplement or that
there has been no adverse change, or any event reasonably likely to
involve any adverse change, in the prospects or financial or trading
position of Novo Nordisk A/S since the date thereof or, if the
prospectus is supplemented after the date thereof, the date of the
relevant supplement or that any other information supplied in
connection with the notes is correct at any time subsequent to the
date on which it is supplied or, if different, the date indicated in
the document containing the same.
The prospectus is not intended to provide the basis of any credit
or any other evaluation and should not be considered as a
recommendation by Novo Nordisk A/S that any recipient of the
prospectus should invest in the notes. Prospective investors should
make an independent assessment as to whether the information in the
prospectus is relevant to their situation, and any investment in the
notes should be based on the information regarding the investor's
specific circumstances that the investor may deem necessary and only
if the notes are consistent with the investor’s financial
The distribution of the prospectus and the offering or sale of
notes in certain jurisdictions may be restricted by law. The
prospectus may not be distributed or otherwise made available and
the notes may not be offered or sold, directly or indirectly, in any
jurisdiction, unless such distribution, offering or sale is
permitted under applicable laws in the relevant jurisdiction.
The notes have not been and will not be registered under the
United States Securities Act of 1933, as amended (the
"Securities Act") and may not be offered or sold within
the United States or to, or for the account or benefit of, U.S.
persons except in certain transactions exempt from the registration
requirements of the Securities Act.
References above to the “prospectus” are to the prospectus as
supplemented from time to time.